Compliance with glibenclamide treatment in non-insulin-dependent diabetic patients
โ Scribed by Babiker, I E ;Jerrom, D W A ;McInerney, D ;Hartog, M
- Publisher
- John Wiley and Sons
- Year
- 1991
- Tongue
- English
- Weight
- 214 KB
- Volume
- 8
- Category
- Article
- ISSN
- 1357-8170
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Compliance with glibenclamide therapy was tested in a group of 18 nonโinsulinโdependent diabetic patients. A considerable degree of nonโcompliance was found โ only nine (50%) achieved a compliance score of 95โ105% at an unscheduled home visit. Five (28%) were found to be taking more than the prescribed amount.
A significant relationship was found between taking less than the prescribed amount and somatic symptoms and indices of social dysfunction.
๐ SIMILAR VOLUMES
We have studied the absorption of glibenclamide 10 mg as a single morning dose in 7 patients with non-insulin-dependent diabetes mellitus, comparing normoglycaemic and hyperglycaemic states. The maximal glibenclamide plasma concentrations were significantly higher in the normoglycaemic than in the h
The effects of combined insulin and sulfonylurea therapy on glycaemic control and B-cell function was studied in 15 Type 2 (non-insulin-dependent) diabetic patients who had failed on treatment with oral hypoglycaemic agents. The patients were first treated with insulin alone for four months. Five pa
The aim of our cross-sectional case-control study was to evaluate putative mechanisms of the increased cardiac morbidity and mortality in NIDDM patients with or without diabetic nephropathy. Fifty-one NIDDM patients with diabetic nephropathy (38 males, age 61 ยฑ 8 years, group 1), 53 NIDDM patients w
The disappearance rate of insulin antibodies was studied after cessation of insulin treatment which had been given for 3 months to 6 years in 42 Type 2 (non-insulin-dependent) diabetic patients. Insulin antibodies were measured before and 15 days after interruption of insulin treatment, and every 30